動物用ワクチンの世界市場2021年-2028年:種類別(弱毒化ワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、複合ワクチン、組換えワクチン、DNAワクチン)、動物別

◆英語タイトル:Animal Vaccines Market by Type (Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vaccines, DNA Vaccines) and Animal type (Companion Animal, Livestock Animal and Aquaculture): Global Opportunity Analysis and Industry Forecast, 2021–2028
◆商品コード:AMR21JU040
◆発行会社(リサーチ会社):Allied Market Research
◆発行日:2021年5月26日
◆ページ数:210
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD6,168 ⇒換算¥678,480見積依頼/購入/質問フォーム
5 UserUSD6,929 ⇒換算¥762,190見積依頼/購入/質問フォーム
Enterprise UserUSD9,663 ⇒換算¥1,062,930見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はAllied Market Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Allied Market Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査資料では、動物用ワクチンの世界市場について調査し、イントロダクション、エグゼクティブサマリー、市場概要、種類別(弱毒化ワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、結合型ワクチン)分析、動物種類別(コンパニオンアニマル、家畜、水産養殖)分析、地域別分析、企業情報などを掲載しています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・動物用ワクチンの世界市場規模:種類別(弱毒化ワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、結合型ワクチン)
・動物用ワクチンの世界市場規模:動物種類別(コンパニオンアニマル、家畜、水産養殖)
・動物用ワクチンの世界市場規模:地域別
・企業情報
【レポートの概要】

Veterinary vaccines play a significant role in the protection of animal and public health, ensuring efficacy in the productivity of food animal sufficing the feed of ever-increasing human population. Animal vaccines have also reduced the risks posed by heavy dosage of antibiotics to food and companion animal. Veterinary vaccinations not only benefit animal health but also have a major effect on the public health by aiding in elimination of zoonotic diseases, which transmit from animal to humans. Injecting against rabies vaccines in domestic animal and wildlife helped in maximum elimination of human rabies in the developed countries.

Developments in the genetic engineering technology have led to the production of new vaccines such as gene-deleted marker vaccines, virus-like-particle vaccines, recombinant modified live virus vaccines, chimeric vaccines, and DNA vaccines. Utilization of animal vaccines on large scale is necessary to enable effective control of animal diseases and requires vaccines to be available at affordable prices. Technological advancements in vaccine technology helps achieve reduction in the cost of veterinary vaccines.

The global animal vaccines market was valued at $9,093.9 million in 2020, and is projected to reach $13,780.6 million by 2028, registering a CAGR of 5.3% from 2021 to 2028. The market is expected to witness moderate growth during the forecast period, owing to the increase in adoption of companion animal worldwide and rise in the awareness about animal health with respect to livestock and pet animal. In addition, increase in meat and milk consumption and rise in the emergence of zoonotic diseases supplement the animal vaccines market growth. However, high cost of vaccine production and storage and unnecessary excessive vaccine administration to animal hamper the market growth. Moreover, lack of awareness regarding animal welfare among pet owners hinders the expansion of the animal vaccines market.

The animal vaccines market is segmented on the basis of product type, animal type, and region. By product type, the market is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. By animal type, the market is segmented into companion animal, livestock animal, and aquaculture. The companion animal segment is further segmented into cats and dogs. The livestock animal segment is further classified into cattle, pigs, poultry, sheep, and others (goats, horses, asses, camel, and others). By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
 This report entails a detailed quantitative analysis along with the current global animal vaccines market trends from 2020 to 2028 to identify the prevailing opportunities along with the strategic assessment.
 The global animal vaccines market forecast is studied from 2021 to 2028.
 The animal vaccines market size and estimations are based on a comprehensive analysis of key developments in the industry.
 A qualitative analysis based on innovative products facilitates strategic business planning.
 The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global animal vaccines market.

KEY MARKET SEGMENTS
By Type
• Attenuated Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• Conjugate Vaccines
• Recombinant Vaccines
• DNA Vaccines

By Animal Type
• Companion animal
o Dogs
o Cats
• Livestock animal
o Cattle
o Pigs
o Poultry
o Sheep
o Others
• Aquaculture

By Region
o North America
 U.S.
 Canada
 Mexico
o Europe
 Germany
 France
 UK
 Italy
 Rest of Europe
o Asia-Pacific
 Japan
 China
 Australia
 India
 South Korea
 Rest of Asia-Pacific
o LAMEA
 Brazil
 Saudi Arabia
 Rest of LAMEA

KEY MARKET PLAYERS
• Merck & Co.
• Zoetis Inc.
• Ceva Santé Animale
• Sanofi S.A.
• Romvac
• Vaxxinova GmbH
• Biovac
• Anicon Labor GmbH
• Merial
• Boehringer Ingelheim Gmb

【レポートの目次】

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits to the stakeholders
1.3.Key market segments
1.4.Research Methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top winning strategies
3.2.2.Top investment pockets

3.3.Government Regulations

3.3.1.Center for Veterinary Biologics (CVB)

3.4.Top player positioning
3.5.Porter’s five forces analysis
3.6.Market dynamics

3.6.1.Drivers

3.6.1.1.Growth in demand for pet insurance
3.6.1.2.Increase in prevalence of animal diseases
3.6.1.3.Growth in ownership of companion animal
3.6.1.4.Rise in animal health expenditure

3.6.2.Restraints

3.6.2.1.Highly competitive meat and milk prices
3.6.2.2.Adverse impact of veterinary vaccines on human and animal health

3.6.3.Opportunities

3.6.3.1.Advancement in vaccine products
3.6.3.2.Increase in demand for hybrid animal

CHAPTER 4:ANIMAL VACCINES MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Attenuated Vaccines

4.2.1.Key market trends, key growth factors and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.Inactivated Vaccines

4.3.1.Key market trends, key growth factors and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

4.4.Subunit Vaccines

4.4.1.Key market trends, key growth factors and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country

4.5.Toxoid Vaccines

4.5.1.Key market trends, key growth factors and opportunities
4.5.2.Market size and forecast
4.5.3.Market analysis, by country

4.6.Conjugate Vaccines

4.6.1.Key market trends, key growth factors and opportunities
4.6.2.Market size and forecast
4.6.3.Market analysis, by country

4.7.Recombinant Vaccines

4.7.1.Key market trends, key growth factors and opportunities
4.7.2.Market size and forecast
4.7.3.Market analysis, by country

4.8.DNA Vaccines

4.8.1.Key market trends, key growth factors and opportunities
4.8.2.Market size and forecast
4.8.3.Market analysis, by country

CHAPTER 5:ANIMAL VACCINES MARKET, BY ANIMAL TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Companion animal

5.2.1.Market size and forecast, by type

5.2.1.1.Dogs

5.2.1.1.1.Market size and forecast

5.2.1.2.Cats

5.2.1.2.1.Market size and forecast

5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country

5.3.Livestock Animal

5.3.1.1.Cattle

5.3.1.1.1.Market size and forecast

5.3.1.2.Pigs

5.3.1.2.1.Market size and forecast

5.3.1.3.Poultry

5.3.1.3.1.Market size and forecast

5.3.1.4.Sheep

5.3.1.4.1.Market size and forecast

5.3.1.5.Others

5.3.1.5.1.Market size and forecast

5.3.2.Market size and forecast
5.3.3.Market analysis, by country

5.4.Aquaculture

5.4.1.Market size and forecast
5.4.2.Market analysis, by country

CHAPTER 6:ANIMAL VACCINES MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends
6.2.2.Key growth factors and opportunities
6.2.3.Market size and forecast, by product
6.2.4.Market size and forecast, by animal type
6.2.5.Market size and forecast, by country

6.2.5.1.U.S. market size and forecast, by product
6.2.5.2.U.S. market size and forecast, by animal type
6.2.5.3.Canada market size and forecast, by product
6.2.5.4.Canada market size and forecast, by animal type
6.2.5.5.Mexico market size and forecast, by product
6.2.5.6.Mexico market size and forecast, by animal type

6.3.Europe

6.3.1.Key market trends
6.3.2.Key growth factors and opportunities
6.3.3.Market size and forecast, by product
6.3.4.Market size and forecast, by animal type
6.3.5.Market size and forecast, by country

6.3.5.1.Germany market size and forecast, by product
6.3.5.2.Germany market size and forecast, by animal type
6.3.5.3.France market size and forecast, by product
6.3.5.4.France market size and forecast, by animal type
6.3.5.5.UK market size and forecast, by product
6.3.5.6.UK market size and forecast, by animal type
6.3.5.7.Italy market size and forecast, by product
6.3.5.8.Italy market size and forecast, by animal type
6.3.5.9.Rest of Europe market size and forecast, by product
6.3.5.10.Rest of Europe market size and forecast, by animal type

6.4.Asia-Pacific

6.4.1.Key market trends
6.4.2.Key growth factors and opportunities
6.4.3.Market size and forecast, by product
6.4.4.Market size and forecast, by animal type
6.4.5.Market size and forecast, by country

6.4.5.1.Japan market size and forecast, by product
6.4.5.2.Japan market size and forecast, by animal type
6.4.5.3.China market size and forecast, by product
6.4.5.4.China market size and forecast, by animal type
6.4.5.5.Australia market size and forecast, by product
6.4.5.6.Australia market size and forecast, by animal type
6.4.5.7.India market size and forecast, by product
6.4.5.8.India market size and forecast, by animal type
6.4.5.9.South Korea market size and forecast, by product
6.4.5.10.South Korea market size and forecast, by animal type
6.4.5.11.Rest of Asia-Pacific market size and forecast, by product
6.4.5.12.Rest of Asia-Pacific market size and forecast, by animal type

6.5.LAMEA

6.5.1.Key market trends
6.5.2.Key growth factors and opportunities
6.5.3.Market size and forecast, by product
6.5.4.Market size and forecast, by animal type
6.5.5.Market size and forecast, by country

6.5.5.1.Brazil market size and forecast, by product
6.5.5.2.Brazil market size and forecast, by animal type
6.5.5.3.Saudi Arabia market size and forecast, by product
6.5.5.4.Saudi Arabia market size and forecast, by animal type
6.5.5.5.Rest of LAMEA market size and forecast, by product
6.5.5.6.Rest of LAMEA market size and forecast, by animal type

CHAPTER 7:COMPANY PROFILES

7.1.Anicon Labor GmbH

7.1.1.Company overview
7.1.2.Company snapshot
7.1.3.Operating business segments
7.1.4.Product portfolio

7.2.Boehringer Ingelheim GmbH

7.2.1.Company overview
7.2.2.Operating business segments
7.2.3.Business performance

7.3.Ceva Santé Animale

7.3.1.Company overview
7.3.2.Company snapshot
7.3.3.Product portfolio
7.3.4.Business performance
7.3.5.Key strategic moves & developments

7.4.Hygieia Biological Laboratories

7.4.1.Company overview
7.4.2.Company snapshot
7.4.3.Operating business segments
7.4.4.Product portfolio

7.5.Merck & company Inc.

7.5.1.Company overview
7.5.2.Company snapshot
7.5.3.Operating business segments
7.5.4.Product portfolio
7.5.5.Business performance
7.5.6.Key strategic moves and developments

7.6.Romvac company S.A.

7.6.1.Company overview
7.6.2.Company snapshot
7.6.3.Operating business segments
7.6.4.Product portfolio

7.7.Sanofi S.A.

7.7.1.Company overview
7.7.2.Company snapshot
7.7.3.Operating business segments
7.7.4.Product portfolio
7.7.5.Business performance
7.7.6.Key strategic moves and developments

7.8.Vaxxinova Gmbh-Germany

7.8.1.Company overview
7.8.2.Company snapshot
7.8.3.Operating business segments
7.8.4.Product portfolio
7.8.5.Key strategic moves and developments

7.9.Virbac S.A

7.9.1.Company overview
7.9.2.Company snapshot
7.9.3.Operating business segments
7.9.4.Product portfolio
7.9.5.Business performance

7.10.Zoetis Inc.

7.10.1.Company overview
7.10.2.Company snapshot
7.10.3.Operating business segments
7.10.4.Product portfolio
7.10.5.Business performance
7.10.6.Key strategic moves & developments

LIST OF TABLES

TABLE 01.NUMBER OF U.S. HOUSEHOLDS THAT OWN A PET, BY TYPE OF ANIMAL (MILLION)
TABLE 02.POPULATION OF DOGS AND CATS IN EUROPEAN COUNTRIES, 2019
TABLE 03.GLOBAL ANIMAL VACCINES MARKET, BY PRODUCT TYPE 2020-2028, ($MILLION)
TABLE 04.ATTENUATED ANIMAL VACCINES MARKET, BY REGION, 2020-2028, ($MILLION)
TABLE 05.INACTIVATED ANIMAL VACCINES MARKET, BY REGION, 2020-2028, ($MILLION)
TABLE 06.SUBUNIT ANIMAL VACCINES MARKET, BY REGION, 2020-2028, ($MILLION)
TABLE 07.TOXOID ANIMAL VACCINES MARKET, BY REGION, 2020-2028, ($MILLION)
TABLE 08.CONJUGATE ANIMAL VACCINES MARKET, BY REGION, 2020-2028, ($MILLION)
TABLE 09.RECOMBINANT ANIMAL VACCINES MARKET, BY REGION, 2020-2028, ($MILLION)
TABLE 10.DNA ANIMAL VACCINES MARKET, BY REGION, 2020-2028, ($MILLION)
TABLE 11.GLOBAL ANIMAL VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 12.COMPANION ANIMAL VACCINES MARKET, BY TYPE, 2020-2028, ($MILLION)
TABLE 13.COMPANION ANIMAL VACCINES MARKET, BY REGION, 2020-2028, ($MILLION)
TABLE 14.ANIMAL VACCINES MARKET FOR LIVESTOCK, BY REGION, 2020-2028, ($MILLION)
TABLE 15.ANIMAL VACCINES MARKET FOR AQUACULTURE, BY REGION, 2020-2028, ($MILLION)
TABLE 16.ANIMAL VACCINES MARKET, BY GEOGRAPHY 2020-2028, ($MILLION)
TABLE 17.NORTH AMERICA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 18.NORTH AMERICA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 19.NORTH AMERICA ANIMAL VACCINES MARKET, BY COUNTRY, 2020-2028, ($MILLION)
TABLE 20.U.S. ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 21.U.S. VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 22.CANADA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 23.CANADA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 24.MEXICO ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 25.MEXICO VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 26.EUROPE ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 27.EUROPE VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 28.EUROPE ANIMAL VACCINES MARKET, BY COUNTRY, 2020-2028, ($MILLION)
TABLE 29.GERMANY ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 30.GERMANY VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 31.FRANCE ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 32.FRANCE VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 33.UK ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 34.UK VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 35.ITALY ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 36.ITALY VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 37.REST OF EUROPE ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 38.REST OF EUROPE VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 39.ASIA-PACIFIC ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 40.ASIA-PACIFIC VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 41.ASIA-PACIFIC ANIMAL VACCINES MARKET, BY COUNTRY, 2020-2028, ($MILLION)
TABLE 42.JAPAN ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 43.JAPAN VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 44.CHINA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 45.CHINA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 46.AUSTRALIA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 47.AUSTRALIA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 48.INDIA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 49.INDIA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 50.SOUTH KOREA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 51.SOUTH KOREA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 52.REST OF ASIA-PACIFIC ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 53.REST OF ASIA-PACIFIC VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 54.LAMEA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 55.LAMEA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 56.LAMEA ANIMAL VACCINES MARKET, BY COUNTRY, 2020-2028, ($MILLION)
TABLE 57.BRAZIL ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 58.BRAZIL VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 59.SAUDI ARABIA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 60.SAUDI ARABIA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 61.REST OF LAMEA ANIMAL VACCINES MARKET, BY PRODUCT, 2020-2028, ($MILLION)
TABLE 62.REST OF LAMEA VACCINES MARKET, BY ANIMAL TYPE, 2020-2028, ($MILLION)
TABLE 63.ANICON: COMPANY SNAPSHOT
TABLE 64.ANICON: OPERATING SEGMENTS
TABLE 65.ANICON: PRODUCT PORTFOLIO
TABLE 66.BOEHRINGER: COMPANY SNAPSHOT
TABLE 67.BOEHRINGER: OPERATING SEGMENTS
TABLE 68.CEVA: COMPANY SNAPSHOT
TABLE 69.CEVA: PRODUCT PORTFOLIO
TABLE 70.HYGIEIA: COMPANY SNAPSHOT
TABLE 71.HYGIEIA: OPERATING SEGMENTS:
TABLE 72.HYGIEIA: PRODUCT PORTFOLIO
TABLE 73.MERCK: COMPANY SNAPSHOT
TABLE 74.MERCK: OPERATING SEGMENTS
TABLE 75.MERCK: PRODUCT PORTFOLIO
TABLE 76.ROMVAC: COMPANY SNAPSHOT
TABLE 77.ROMVAC: OPERATING SEGMENTS
TABLE 78.ROMVAC: PRODUCT PORTFOLIO
TABLE 79.SANOFI: COMPANY SNAPSHOT
TABLE 80.SANOFI: OPERATING SEGMENTS
TABLE 81.SANOFI: PRODUCT PORTFOLIO
TABLE 82.VAXXINOVA: COMPANY SNAPSHOT
TABLE 83.VAXXINOVA: OPERATING SEGMENTS
TABLE 84.VAXXINOVA: PRODUCT PORTFOLIO
TABLE 85.VIRBAC: COMPANY SNAPSHOT
TABLE 86.VIRBAC: OPERATING SEGMENTS
TABLE 87.VIRBAC: PRODUCT PORTFOLIO
TABLE 88.ZOETIS: COMPANY SNAPSHOT
TABLE 89.ZOETIS: OPERATING SEGMENTS
TABLE 90.ZOETIS: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2018–2021*)
FIGURE 02.TOP WINNING STRATEGIES: BY DEVELOPMENT (2018–2021*)
FIGURE 03.TOP WINNING STRATEGIES: BY COMPANY (2018–2021*)
FIGURE 04.TOP INVESTMENT POCKETS: ANIMAL VACCINES MARKET
FIGURE 05.TOP PLAYER POSITIONING, 2020
FIGURE 06.LOW BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTION
FIGURE 09.MODERATE THREAT OF NEW ENTRANT
FIGURE 10.HIIGH COMPETITIVE RIVALRY
FIGURE 11.U.S. PET INDUSTRY EXPENDITURE, 2010–2019 ($BILLION)
FIGURE 12.COMPARATIVE SHARE ANALYSIS OF ATTENUATED ANIMAL VACCINES MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF INACTIVATED ANIMAL VACCINES MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF SUBUNIT ANIMAL VACCINES MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF TOXOID ANIMAL VACCINES MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 16.COMPARATIVE SHARE ANALYSIS OF CONJUGATE ANIMAL VACCINES MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 17.COMPARATIVE SHARE ANALYSIS OF RECOMBINANT ANIMAL VACCINES MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 18.COMPARATIVE SHARE ANALYSIS OF DNA ANIMAL VACCINES MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 19.ANIMAL VACCINES MARKET FOR DOGS, 2020–2028 ($MILLION)
FIGURE 20.ANIMAL VACCINES MARKET FOR CATS, 2020–2028 ($MILLION)
FIGURE 21.COMPARATIVE SHARE ANALYSIS OF COMPANION ANIMAL VACCINES MARKET, BY COUNTRY, 2020 & 2028 (%)
FIGURE 22.ANIMAL VACCINES MARKET FOR CATTLE, 2020–2028 ($MILLION)
FIGURE 23.ANIMAL VACCINES MARKET FOR PIGS, 2020–2028 ($MILLION)
FIGURE 24.ANIMAL VACCINES MARKET FOR POULTRY, 2020–2028 ($MILLION)
FIGURE 25.ANIMAL VACCINES MARKET FOR SHEEP, 2020–2028 ($MILLION)
FIGURE 26.ANIMAL VACCINES MARKET FOR OTHERS, 2020–2028 ($MILLION)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF ANIMAL VACCINES MARKET FOR LIVESTOCK, BY COUNTRY, 2020 & 2028 (%)
FIGURE 28.COMPARATIVE SHARE ANALYSIS OF ANIMAL VACCINES MARKET FOR AQUACULTURE, BY COUNTRY, 2020 & 2028 (%)
FIGURE 29.BOEHRINGER: REVENUE, 2018–2020 ($MILLION)
FIGURE 30.BOEHRINGER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 31.BOEHRINGER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 32.CEVA: NET SALES, 2018–2020 ($MILLION)
FIGURE 33.CEVA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 34.MERCK: NET SALES, 2018–2020 ($MILLION)
FIGURE 35.MERCK: REVENUE SHARE BY PRODUCT, 2020 (%)
FIGURE 36.MERCK: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 37.SANOFI: NET SALES, 2018–2020 ($MILLION)
FIGURE 38.SANOFI: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 39.SANOFI: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 40.VIRBAC: REVENUE, 2018–2020 ($MILLION)
FIGURE 41.VIRBAC: REVENUE SHARE BY PRODUCT CATEGORY, 2020 (%)
FIGURE 42.VIRBAC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 43.ZOETIS: NET SALES, 2018–2020 ($MILLION)
FIGURE 44.ZOETIS: REVENUE SHARE BY PRODUCT, 2020 (%)
FIGURE 45.ZOETIS: REVENUE SHARE BY REGION, 2020 (%)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[動物用ワクチンの世界市場2021年-2028年:種類別(弱毒化ワクチン、不活化ワクチン、サブユニットワクチン、トキソイドワクチン、複合ワクチン、組換えワクチン、DNAワクチン)、動物別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆